464 related articles for article (PubMed ID: 29468856)
1. Chemoresistance in ovarian cancer: exploiting cancer stem cell metabolism.
Li SS; Ma J; Wong AST
J Gynecol Oncol; 2018 Mar; 29(2):e32. PubMed ID: 29468856
[TBL] [Abstract][Full Text] [Related]
2. Ovarian cancer stem cells: Molecular concepts and relevance as therapeutic targets.
Ahmed N; Abubaker K; Findlay JK
Mol Aspects Med; 2014 Oct; 39():110-25. PubMed ID: 23811037
[TBL] [Abstract][Full Text] [Related]
3. Eliminating ovarian cancer stem cells: a potential therapeutic target for ovarian cancer chemoresistance.
Wang X; Li X; Fu X; Bai M; Li X; Mei Q; Nie J; Wu Z; Han W
Curr Protein Pept Sci; 2015; 16(4):270-8. PubMed ID: 25929861
[TBL] [Abstract][Full Text] [Related]
4. Multiple blocks in the engagement of oxidative phosphorylation in putative ovarian cancer stem cells: implication for maintenance therapy with glycolysis inhibitors.
Alvero AB; Montagna MK; Sumi NJ; Joo WD; Graham E; Mor G
Oncotarget; 2014 Sep; 5(18):8703-15. PubMed ID: 25237928
[TBL] [Abstract][Full Text] [Related]
5. Epithelial mesenchymal transition and cancer stem cell-like phenotypes facilitate chemoresistance in recurrent ovarian cancer.
Ahmed N; Abubaker K; Findlay J; Quinn M
Curr Cancer Drug Targets; 2010 May; 10(3):268-78. PubMed ID: 20370691
[TBL] [Abstract][Full Text] [Related]
6. Ovarian cancer stem cell: A potential therapeutic target for overcoming multidrug resistance.
Mihanfar A; Aghazadeh Attari J; Mohebbi I; Majidinia M; Kaviani M; Yousefi M; Yousefi B
J Cell Physiol; 2019 Apr; 234(4):3238-3253. PubMed ID: 30317560
[TBL] [Abstract][Full Text] [Related]
7. Nanoparticle Delivery of TWIST Small Interfering RNA and Anticancer Drugs: A Therapeutic Approach for Combating Cancer.
Glackin CA
Enzymes; 2018; 44():83-101. PubMed ID: 30360816
[TBL] [Abstract][Full Text] [Related]
8. Cancer stem cells, metabolism, and therapeutic significance.
Yang M; Liu P; Huang P
Tumour Biol; 2016 May; 37(5):5735-42. PubMed ID: 26864589
[TBL] [Abstract][Full Text] [Related]
9. Rad6 upregulation promotes stem cell-like characteristics and platinum resistance in ovarian cancer.
Somasagara RR; Tripathi K; Spencer SM; Clark DW; Barnett R; Bachaboina L; Scalici J; Rocconi RP; Piazza GA; Palle K
Biochem Biophys Res Commun; 2016 Jan; 469(3):449-55. PubMed ID: 26679603
[TBL] [Abstract][Full Text] [Related]
10. S100B promotes chemoresistance in ovarian cancer stem cells by regulating p53.
Yang T; Cheng J; You J; Yan B; Liu H; Li F
Oncol Rep; 2018 Sep; 40(3):1574-1582. PubMed ID: 29956807
[TBL] [Abstract][Full Text] [Related]
11. Tumour microenvironment and metabolic plasticity in cancer and cancer stem cells: Perspectives on metabolic and immune regulatory signatures in chemoresistant ovarian cancer stem cells.
Ahmed N; Escalona R; Leung D; Chan E; Kannourakis G
Semin Cancer Biol; 2018 Dec; 53():265-281. PubMed ID: 30317036
[TBL] [Abstract][Full Text] [Related]
12. Overcoming cisplatin resistance of ovarian cancer cells by targeting HIF-1-regulated cancer metabolism.
Ai Z; Lu Y; Qiu S; Fan Z
Cancer Lett; 2016 Apr; 373(1):36-44. PubMed ID: 26801746
[TBL] [Abstract][Full Text] [Related]
13. [The role of cancer stem cells in progressive growth and resistance of ovarian cancer: true or fiction?].
Bar JK; Grelewski P; Lis-Nawara A; Drobnikowska K
Postepy Hig Med Dosw (Online); 2015 Sep; 69():1077-86. PubMed ID: 26400893
[TBL] [Abstract][Full Text] [Related]
14. Neil 1 deficiency facilitates chemoresistance through upregulation of RAD18 expression in ovarian cancer stem cells.
Shukla D; Mandal T; Srivastava AK
Biochem Biophys Res Commun; 2024 Jun; 712-713():149907. PubMed ID: 38636303
[TBL] [Abstract][Full Text] [Related]
15. A Small-molecule Kinase Inhibitor, CEP-1347, Inhibits Survivin Expression and Sensitizes Ovarian Cancer Stem Cells to Paclitaxel.
Togashi K; Okada M; Yamamoto M; Suzuki S; Sanomachi T; Seino S; Yamashita H; Kitanaka C
Anticancer Res; 2018 Aug; 38(8):4535-4542. PubMed ID: 30061219
[TBL] [Abstract][Full Text] [Related]
16. Metabolic approaches to overcoming chemoresistance in ovarian cancer.
Suh DH; Kim MK; No JH; Chung HH; Song YS
Ann N Y Acad Sci; 2011 Jul; 1229():53-60. PubMed ID: 21793839
[TBL] [Abstract][Full Text] [Related]
17. Cancer stem cells in prostate cancer chemoresistance.
Ni J; Cozzi P; Hao J; Duan W; Graham P; Kearsley J; Li Y
Curr Cancer Drug Targets; 2014; 14(3):225-40. PubMed ID: 24720286
[TBL] [Abstract][Full Text] [Related]
18. Lysine-specific demethylase KDM3A regulates ovarian cancer stemness and chemoresistance.
Ramadoss S; Sen S; Ramachandran I; Roy S; Chaudhuri G; Farias-Eisner R
Oncogene; 2017 Mar; 36(11):1537-1545. PubMed ID: 27694900
[TBL] [Abstract][Full Text] [Related]
19. Ovarian cancer stem cells and targeted therapy.
Keyvani V; Farshchian M; Esmaeili SA; Yari H; Moghbeli M; Nezhad SK; Abbaszadegan MR
J Ovarian Res; 2019 Dec; 12(1):120. PubMed ID: 31810474
[TBL] [Abstract][Full Text] [Related]
20. Cancer stem cell metabolism: a potential target for cancer therapy.
Deshmukh A; Deshpande K; Arfuso F; Newsholme P; Dharmarajan A
Mol Cancer; 2016 Nov; 15(1):69. PubMed ID: 27825361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
